Polyphenols as Promising Drugs against Main Breast Cancer Signatures
Open Access
- 7 November 2017
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 6 (4), 88
- https://doi.org/10.3390/antiox6040088
Abstract
Breast cancer is one of the most common neoplasms worldwide, and in spite of clinical and pharmacological advances, it is still a clinical problem, causing morbidity and mortality. On the one hand, breast cancer shares with other neoplasms some molecular signatures such as an imbalanced redox state, cell cycle alterations, increased proliferation and an inflammatory status. On the other hand, breast cancer shows differential molecular subtypes that determine its prognosis and treatment. These are characterized mainly by hormone receptors especially estrogen receptors (ERs) and epidermal growth factor receptor 2 (HER2). Tumors with none of these receptors are classified as triple negative breast cancer (TNBC) and are associated with a worse prognosis. The success of treatments partially depends on their specificity and the adequate molecular classification of tumors. New advances in anticancer drug discovery using natural compounds have been made in the last few decades, and polyphenols have emerged as promising molecules. They may act on various molecular targets because of their promiscuous behavior, presenting several physiological effects, some of which confer antitumor activity. This review analyzes the accumulated evidence of the antitumor effects of plant polyphenols on breast cancer, with special attention to their activity on ERs and HER2 targets and also covering different aspects such as redox balance, uncontrolled proliferation and chronic inflammation.This publication has 240 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical reviewBreast Cancer Research and Treatment, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The pros and cons of phytoestrogensFrontiers in Neuroendocrinology, 2010
- Air pollution and circulating biomarkers of oxidative stressAir Quality, Atmosphere & Health, 2010
- Redox-optimized ROS balance: A unifying hypothesisBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Epigenetic Regulation in Estrogen Receptor Positive Breast Cancer—Role in Treatment ResponseJournal of Mammary Gland Biology and Neoplasia, 2010
- Role of autophagy in cancerNature Reviews Cancer, 2007
- Concordance among Gene-Expression–Based Predictors for Breast CancerThe New England Journal of Medicine, 2006
- Inflammation and cancerNature, 2002